Afinum supports Saas provider p36 in the life science industry

Munich — Afinum 9 has ente­red into a growth part­ner­ship with reinves­t­ing foun­ders Robin Wenne­muth and Patrick Pfau. This tran­sac­tion expands our stra­tegy to build an SAP-focu­­sed verti­cal soft­ware group for the life science indus­try, which was initia­ted with the invest­ment in myme­di­set GmbH. 

p36 was foun­ded in 2015 and is head­quar­te­red in Bad Hers­feld, Germany. The company supports life science and medtech compa­nies world­wide in meeting key regu­la­tory and compli­ance requi­re­ments. The company’s 47-strong team offers two central soft­ware suites: Unique Device Iden­ti­fi­ca­tion (UDI) and Cloud Service Quali­fi­ca­tion (CSQ). The UDI solu­ti­ons are aimed at MedTech custo­mers seeking holi­stic and highly auto­ma­ted compli­ance with UDI regu­la­ti­ons world­wide, while the CSQ solu­tion ensu­res GxP compli­ance for life science custo­mers in cloud infrastructures. 

Looking ahead, p36 is well posi­tio­ned to capi­ta­lize on the growth oppor­tu­ni­ties arising from the incre­asing comple­xity of regu­la­tory and compli­ance requi­re­ments within the SAP ecosys­tem and beyond. Robin Wenne­muth and Patrick Pfau will remain Mana­ging Direc­tors and will conti­nue to drive the company’s growth. 

Advi­sor to AFINUM: 

Valan­tic, Green­fort, Alva­rez & Marsal and Ebner Stolz supported the tran­sac­tion process.

About AFINUM

Afinum Manage­ment GmbH is an inde­pen­dent finan­cial inves­tor that is wholly owned by its manage­ment and has offices in Munich, Frank­furt and Zurich. The company specia­li­zes in majo­rity invest­ments in finan­ci­ally sound, ambi­tious medium-sized compa­nies, prima­rily in the DACH region. As a renow­ned succes­sion specia­list, Afinum has supported more than 100 compa­nies over the last 25 years in their tran­si­tion from entre­pre­­neur-led to mana­­ger-led orga­niza­ti­ons and has estab­lished itself as a trus­ted part­ner. — www.afinum.de